Image - Barts and The London logo and link to home page Image - divider Image - divider
  Image - Wolfson Institute of Preventive Medicine title and link to Institute home page
Images - preventive medicine, people
  Image - Centre for Environmental and Preventive Medicine title and link to Centre homepage
Centre for Environmental and Preventive Medicine: publications 1996
Alberman E, Pharoah POD. (1996). Needs of special client groups. Children. In: Oxford Textbook of Public Health (Third Edition). Holland WW, Detels R, Knox EG (Eds). Oxford: Oxford University Press; 1379-1396.
Brookes ME, Alberman E. (1996). Early mortality and morbidity in children with Down's syndrome diagnosed in two regional health authorities in 1989. J Med Screen 3: 7-11.
Dickinson CJ. (1996). De-engineering in the NHS. BMJ 312: 1617.
Dickinson CJ. (1996). Cerebral oxidative metabolism in hypertension (Editorial review). Clin Sci 91: 539-550.
Goodman R, Alberman E. (1996). A twin study of congenital hemiplegia. Dev Med Child Neurol 38: 3-12.
Hackshaw AK. (1996). Screening for breast cancer in young women using breast self-examination. In: Evidence-guided Prescribing of the Pill. Hannabord PC, Webb AMC (Eds). London: Royal College of General Pracitioners, Parthenon Publishing Group; 217-226.
Hacksaw AK, Wald NJ, Haddow JE. (1996). Down's syndrome screening with nuchal translucency. Lancet 348: 1740.
Ibison J, Swerdlow AJ, Head JA, Marmot M. (1996). Maternal mortality in England and Wales 1970-1985: an analysis by country of birth. Br J Obstet Gynaecol 103: 973-980.
Law MR. (1996). Commentary on salt papers. BMJ 312: 1284-1285.
Law MR. (1996). Commentary: Having too much evidence (depression, suicide, and low serum cholesterol). BMJ 313: 651-652.
Law MR, Hackshaw AK. (1996). Environmental tobacco smoke. Br Med Bull 52: 22-34.
Morris JK. (1996). Should testicular self examination be recommended? J Med Screen 3: 2.
Mutton D, Alberman E, Hook EB for The National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. (1996). Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. J Med Genet 33: 387-394.
Noble J. (1996). Folic acid: preventing neural tube defects. Practice Nursing 7: 31-34.
Noble J. (1996). The natural history of Down syndrome. Genetics and Teratology 5(2).
Noble J, Wald N. (1996). Preventing neural tube defects through folic acid supplementation. Health Visitor 69: 74-75.
Parkes C, Wald NJ, Murphy P, George L, Watt HC, Kirby R, Knekt P, Helzlsouer KJ, Tuomilehto J. (1996). Measurement of prostate specific antigen as a screening test for prostate cancer. BMJ 312: 709-710.
Templeton A, Morris JK, Parslow, W. (1996). Factors that affect outcome of in-vitro fertilisation treatment. Lancet 348: 1402-1406.
Wald N. (1996). Biochemical antenatal screening for open neural tube defects. Association of Clinical Pathologists Year Book 1996 13-14.
Wald NJ. (1996). The B4-you-conceive pill. Lancet 348: 1460.
Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. (1996). Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16: 143-153. (Correction: Prenat Diagn 17:285-290).
Wald NJ, George L. (1996). Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 103: 1173-1174.
Wald NJ, George L, Hackshaw A. (1996). Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 103: 1174-1175.
Wald NJ, George L, Smith D, Densem JW, Petterson K on behalf of the International Prenatal Screening Research Group. (1996). Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 103: 407-412.
Wald NJ, Hacksaw AK. (1996). Risk estimation in Down's syndrome screening. Prenat Diagn 16: 1055-1060.
Wald NJ, Hackshaw AK, Stone R, Sourial NA. (1996). Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol 103: 319-329.
Wald NJ, Huttly W, Wald K, Kennard A. (1996). Down's syndrome screening in UK. Lancet 347: 330.
Wald NJ, Kennard A. (1996). Prenatal screening for neural tube defects and Down's syndrome. In: Emery and Rimoin's Principles and Practice of Medical Genetics (Third Edition). Rimoin DL, Connon JM, Pyeritz RE (Eds). Edinburgh: Churchill Livingstone; 545-562.
Wald NJ, Major P, Murphy P, Parkes C, Frost C, Townsend J. (1996). One and two view mammography in breast cancer. BMJ 312: 509-510.
Wald NJ, Morris JK. (1996). Editorial: What is case-finding? J Med Screen 3: 1.
Wald NJ, Morris JK. (1996). Case finding. J Med Screen 3: 111.
Wald NJ, Watt HC. (1996). Serum markers for Down's syndrome in relation to number of previous births and maternal age. Prenat Diagn 16: 699-703.
Wald N, Watt H. (1996). When marginal costs and benefits should be used in screening. BMJ 312: 1041-1042.
Watt HC, Wald NJ, George L. (1996). Maternal serum inhibin-A in pregnancies with insulin dependent diabetes mellitus: Implications for screening for Down's syndrome. Prenat Diagn 16: 923-926.
Watt HC, Wald NJ, George L. (1996). Maternal serum inhibin-A levels in twin pregnancies: Implications for screening for Down's syndrome. Prenat Diagn 16: 927-929.
Watt HC, Wald NJ, Smith D, Kennard A, Densem J. (1996). Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Prenat Diagn 16: 691-698.
Williams K, Hennessy E, Alberman E. (1996). Cerebral palsy: the effects of twinning, birthweight and gestational age. Arch Dis Childh 75: F178-F182.

Useful links:
  WIPM publications hub

by Wolfson Institute Website Manager © Queen Mary, University of London 2011
Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London, Charterhouse Square, London EC1M 6BQ Tel: 020 7882 3850 Fax: 020 7882 6270